Last A$0.0060 AUD
Change Today -0.001 / -14.29%
Volume 1.8M
As of 2:10 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

immuron ltd (IMC) Snapshot

Open
A$0.0070
Previous Close
A$0.0070
Day High
A$0.0070
Day Low
A$0.0060
52 Week High
11/13/13 - A$0.02
52 Week Low
08/30/13 - A$0.0036
Market Cap
18.0M
Average Volume 10 Days
8.0M
EPS TTM
A$-0.0012
Shares Outstanding
3.0B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMURON LTD (IMC)

Related News

No related news articles were found.

immuron ltd (IMC) Related Businessweek News

No Related Businessweek News Found

immuron ltd (IMC) Details

Immuron Limited, a biopharmaceutical company, is engaged in the research and development, and sale of polyclonal antibodies for the treatment and prevention of various diseases in Australia and internationally. The company’s platform technology enables the development of medicines that target a range of medical needs, including infectious diseases, immune mediated disorders, and cancers. It commercializes its platform derived products through a range of regulatory pathways, including prescription, medical foods, over-the-counter medicines, and dietary supplements. The company offers Travelan, a natural product for the prevention of Travellers’ Diarrhoea. It is also developing IMM 272, a bovine colostrum powder to prevent rotavirus diarrhea; IMM 124-E, a natural product for the treatment of fatty liver and non-alcoholic steatohepatitis/type 2 diabetes; IMM 529 for the treatment of clostridium difficile infection; IMM-363 to treat of side effects caused by chemotherapy or radiation; and IMM-160 to reduce tumour size and suppress liver cancer. Immuron Limited was founded in 1994 and is based in Armadale, Australia.

8 Employees
Last Reported Date: 09/27/13
Founded in 1994

immuron ltd (IMC) Top Compensated Officers

Chief Executive Officer and Vice President of...
Total Annual Compensation: A$228.0K
External Advisor
Total Annual Compensation: A$192.0K
Chief Scientific Officer
Total Annual Compensation: A$102.9K
Compensation as of Fiscal Year 2013.

immuron ltd (IMC) Key Developments

Immuron Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 02:40 PM

Immuron Limited Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 02:40 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Amos Meltzer, Chief Executive Officer and Vice President of Business Development.

Immuron Limited Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 03:00 PM

Immuron Limited Presents at 2014 Asia Biotech Invest Conference, Jun-05-2014 03:00 PM. Venue: Sheraton Hong Kong Hotel & Towers, 20 Nathan Road, Kowloon, Hong Kong. Speakers: Amos Meltzer, Chief Executive Officer and Vice President of Business Development.

Immuron Limited, Special/Extraordinary Shareholders Meeting, May 27, 2014

Immuron Limited, Special/Extraordinary Shareholders Meeting, May 27, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMC:AU A$0.01 AUD -0.001

IMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMC.
View Industry Companies
 

Industry Analysis

IMC

Industry Average

Valuation IMC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 50.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMURON LTD, please visit www.immuron.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.